Lightning Session 3

Co-Moderator(s)

• 

  J. Bradley Layton, PhD, FISPE (he/him/his)

  Director, Epidemiology
  RTI Health Solutions
  Research Triangle Park, United States
• 

  Kourtney Davis, PhD MSPH FISPE (she/her/hers)

  Vice President
  Janssen Research & Development
  Bryn Mawr, United States
• 

  Rachel Sobel, DrPH, FISPE (she/her/hers)

  Executive Director, Head of Pharmacoepidemiology
  Regeneron Pharmaceuticals, Inc.
  Tarrytown, United States
• 

  Lisa Pont, PhD

  Professor of Pharmacy
  Discipline of Pharmacy, University of Technology Sydney, Sydney, NSW, Australia, Australia

Presentations:

• 1:30 PM – 1:35 PM ADT

  Comparative Cardiovascular Risk Associated with Enzalutamide and Abiraterone Use in Patients with Metastatic Castration-Resistant Prostate Cancer
  

  Presenting Author: Yue Cheng, PhD – Institution of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Kentucky
• 1:35 PM – 1:40 PM ADT

  Cardiovascular Risks in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy among the Southern Chinese: a Population-based Cohort Study
  

  Presenting Author: Tung Hiu Li, MPhil – The University of Hong Kong
• 1:40 PM – 1:45 PM ADT

  Risk of thyroid cancer associated with incretin-based drugs among patients with type 2 diabetes
  

  Presenting Author: Sungho Bea, PharmD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
• 1:45 PM – 1:50 PM ADT

  Comparison of Tisagenlecleucel With Historical Treatments For Relapsed or Refractory Diffuse Large B-cell Lymphoma: a Retrospective Study Using External Comparator From the Korean Lymphoma Registry Data
  

  Presenting Author: Ju Hwan Kim, PharmD, PhD (he/him/his) – School of Pharmacy, Sungkyunkwan University, South Korea
• 2:00 PM – 2:05 PM ADT

  COVID-19 Vaccination and the Risk of Abnormal Uterine Bleeding: a population-based self-controlled case series study
  

  Presenting Author: Na-Young Jeong, MS – Department of Health Convergence, Ewha Womans University
• 2:05 PM – 2:10 PM ADT

  Incidence of Diabetes Following COVID-19 Vaccination and SARS-CoV-2 Infection: A Population-Based Cohort Study
  

  Presenting Author: Xi Xiong, Msc – The University of Hong Kong
• 2:10 PM – 2:15 PM ADT

  Safety Monitoring of BNT162b2 (Pfizer-BioNTech) COVID-19 Vaccines in U.S. Children aged 5-17 years
  

  Presenting Author: Patricia C. Lloyd, ScM, PhD – US Food and Drug Administration
• 2:15 PM – 2:20 PM ADT

  Safety of COVID-19 mRNA Vaccination among Young Children in the Vaccine Safety Datalink
  

  Presenting Author: Kristin S. Goddard, MPH (she/her/hers) – Kaiser Permanente Vaccine Study Center - Kaiser Permanente Northern California
• 2:30 PM – 2:35 PM ADT

  Quantifying the Impact of Novel Metastatic Cancer Therapies on Health Disparities in Survival Outcomes Based on Published Aggregate Data
  

  Presenting Author: Gary Schneider, MSPH, ScD – Lumen Value & Access, Healthcare Consultancy Group
• 2:35 PM – 2:40 PM ADT

  Enhancing Clinical Trials By Linking Them to Real-World Data
  

  Presenting Author: Mehdi NajafZadeh, PhD – Medidata AI
• 2:40 PM – 2:45 PM ADT

  Using Real-World Data to Evaluate Trends in Female Elective Contraception Procedures Among Women of Childbearing Age Surrounding Key Legal and Policy Events From 2008 to 2022
  

  Presenting Author: Djeneba Audrey Djibo, PhD – CVS Health
• 2:45 PM – 2:50 PM ADT

  Use of Antiepileptic Drugs During Pregnancy in France between 2010 and 2021
  

  Presenting Author: Pouneh Shahriari, PhD student – EPI-PHARE